Guide to Authors

Welcome to the electronic manuscript submission website for International Journal of Impotence Research. The instructions below are structured so you can quickly and easily answer the following questions:

1. Is my manuscript suitable for International Journal of Impotence Research? (Scope + Editorial Note)
2. How do I format my manuscript for International Journal of Impotence Research? (Format of Papers)
3. How do I submit my manuscript to International Journal of Impotence Research? (Submission of Papers)

OTHER LINKS

• About the journal
• Format of papers
• Preparation of Original Articles
• House style
• Submission of papers
• Editorial policy
• Ethics and bioethics
• Peer review policy
• Corrections
• About npg online services

ABOUT THE JOURNAL

Scope

Topics Covered
questionnaires or scales that measure male or female sexual dysfunction, epidemiologic studies, male hypogonadism, female androgen deficiency, organic and psychogenic male erectile dysfunction, vasculogenic erectile dysfunction, female arousal disorders, rapid and delayed ejaculation, orgasmic dysfunction, penile vascular reconstructive surgery, depression and associated disorders as they relate to male sexual dysfunction, Lower Urinary Tract symptoms, female vascular disorders as they pertain to sexual dysfunction. Studies assessing therapies such as oral therapies, topical therapies, vacuum devices, penile prosthesis, intracavernosal injection are of interest. The effect of CNS or peripheral neurologic disease or spinal cord injury on sexual dysfunction will be entertained. Reports delving into the mechanisms of disease are highly desired. Human and non-human studies are welcome.

Editor	Allen D Seftel, MD
Frequency	6 issues a year
Abstracted in	Index Medicus/MEDLINE Elsevier BIOBASE/Current Awareness in Biological Sciences Current Opinion in Urology Excerpta Medica/EMBASE Current Contents/Clinical Medicine Research Alert SciSearch Science Citation Index UK Health Centre Index

Editorial Note

FORMAT OF PAPERS

Article Types Table

Article Type	Description	Approx Word Count
Original Article	Are scientific reports from original clinical research in sexual medicine and should follow the structure outlined below	The text is limited to 3000 words (including abstract text), a maximum of 7 tables and figures (total), and up to 50 references.
Review	Are usually solicited by the editors. All review articles undergo the same peer-review and editorial process as all other manuscripts submitted to IJIR
Letters to the Editor	Are considered for publication (subject to editing and abridgment) provided they do not contain material that has been submitted or published elsewhere. It must not be signed by any more than three authors and letters referring to a recent IJIR article must be received within six weeks of its publication.	The text, not including references, must not exceed 500 words, with no more than five references and one figure or table.
Editorials	Provide commentary on and analysis of an article in the particular issue of IJIR. They are always solicited.	Editorials are limited to 750 words, with up to 5 references.

Preparation of Original Articles

Abstract and Keywords
The abstract should not exceed 200 words and three to six keywords should be included to aid web searches after publication.

References
Only papers directly related to the article should be cited. Exhaustive lists should be avoided. References should follow the Vancouver format. In the text they should appear as numbers starting at one and at the end of the paper they should be listed (double-spaced) in numerical order corresponding to the order of citation in the text. All authors should be quoted for papers with up to six authors; for papers with more than six authors, the first six only should be quoted, followed by et al. Abbreviations for titles of medical periodicals should conform to those used in the latest edition of Index Medicus. The first and last page numbers for each reference should be provided. Abstracts and letters must be identified as such. Papers in press and papers already submitted for publication may be included in the list of references but no citation is required for work that is not yet submitted for publication.

Journal article, up to six authors:
Abber JC, Lue TF, Orvis BR, McClure RD. Diagnostic test for impotence a comparison of papaverine injections with penile-brachial index and nocturnal penile tumescence. J Urol1986; 135: 923–925.

Journal article, e-pub ahead of print:
Campos AR, Cunha KMA, Santos FA, Silveira ER, Uchoa DEA, Nascimento NRF et al. Relaxant effects of an alkaloid-rich fraction from Aspidosperma ulei root bark. Int J Impot Res 2007; e-pub ahead of print 29 November 2007; doi:10.1038/sj.ijir.3901624.

Journal article, in press:
Chubak B. Impotence and suing for sex in eighteenth-century England. Urology (in press).

Complete book:
Kaplan HS. The New Sex Therapy: Active Treatment of Sexual Dysfunctions, 2nd edn. Brunner/Mazel: New York, 1979.

Chapter in book:
Batra SK, Lardner TJ. Sperm transport in the vas deferens. In: Hafez ESE, ed. Human Semen and Fertility Regulation in Men. CV Mosby: St Louis, MO, 1976, pp 100–106.

Abstract:
Syrjala KL, Abrams JR, Storer B, Heiman JR. Prospective risk factors for five-year sexuality late effects in men and women after haematopoietic cell transplantation. Bone Marrow Transplant 2006; 37(Suppl 1): S4 (abstract 107).

Correspondence:
Thomas J Jr. Erectile dysfunction in patients with chronic renal failure [letter]. J Sex Med 1999; 12: 123–456.

EndNote users should select the International Journal of Impotence Research output style for the correct reference style.

Personal communications must be allocated a number and included in the list of references in the usual way or simply referred to in the text; the authors may choose which method to use. In either case authors must obtain permission from the individual concerned to quote his/her unpublished work.

House Style

Patient Anonymity and Informed Consent
For human studies, International Journal of Impotence Research requires a statement confirming the Declaration of Helsinki protocols were followed and that patients gave their written, informed consent.

Gene Nomenclature
Authors should use approved nomenclature for gene symbols, and use symbols rather than italicized full names (Ttn, not titin). Please consult the appropriate nomenclature databases for correct gene names and symbols. Approved human gene symbols are provided by HUGO Gene Nomenclature Committee (HGNC), e-mail: nome@galton.ucl.ac.uk; see also http://www.gene.ucl.ac.uk/nomenclature. Approved mouse symbols are provided by The Jackson Laboratory, e-mail: nomen@informatics.jax.org; see also http://www.informatics.jax.org/mgihome/nomen. For proposed gene names that are not already approved, please submit the gene symbols to the appropriate nomenclature committees as soon as possible, as these must be deposited and approved before publication of an article. Avoid listing multiple names of genes (or proteins) separated by a slash, as in 'Oct4/Pou5f1', as this is ambiguous (it could mean a ratio, a complex, alternative names or different subunits). Use one name throughout and include the other at first mention: 'Oct4(also known as Pou5f1)'.

Clinical Trials Registration
The International Journal of Impotence Research subscribes to the standards set by the International Committee of Medical Journal Editors in The Lancet (364:911-912, 2004), requiring that all trials that start enrolling participants after July 1, 2005 must be registered in a suitable publicly accessible register before that date in order to be considered for publication. Those trials that started enrollment before July 1, 2005 must have registered before September 13, 2005 to be considered for publication. Suggested registers include http://www.clinicaltrials.gov and http://www.controlled-trials.com. Registration in the former is free, while registration for trials that do not emanate from developing countries carries a $144 charge in the latter. Access to both registries is free.

SUBMISSION OF PAPERS

Upon submission of an original research paper, authors can indicate within the manuscript tracking system whether they wish to pay a one off fee to allow their article to become freely available immediately upon publication. The fee is £2,000/$3,000/€2,400 (plus VAT where applicable) and can be paid via credit card or by requesting an invoice be raised.

By paying this fee authors are permitted to post the final, published, pdf of their article on a website, institutional repository or other free public server immediately on publication.

Upon acceptance, authors must fill out and send back a payment form. This is mandatory and failure to send in the payment form along with the Licence to Publish form will result in the article being published as a standard paper behind access control. The licence to publish form has been amended to offer authors the choice of which licence to use on their paper and these choices are described below:

The first is the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported Licence and allows readers to download the article and share it with others as long as they mention the author and link back to the original article. The article cannot be changed in any way or used commercially.

The second is the Creative Commons Attribution Noncommercial Share Alike 3.0 Unported Licence and allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted.

For further information please see the International Journal of Impotence Research Open FAQs and payment form.

Colour charges

Further information
To find out who to contact for advertising, subscriptions, permissions, papers in production or publishing a supplement, please visit our publisher’s contacts page. Alternatively, you can write to: International Journal of Impotence Research, Nature Publishing Group, The Macmillan Building, 4 Crinan Street, London, N1 9XW, UK.

EDITORIAL POLICY

Statement of Ethics

Peer-review policy

Correction and retraction process

Non-Native Speakers of English
Researchers who are not native speakers of English who submit manuscripts to international journals sometimes receive negative comments from referees or editors about the English-language usage in their manuscripts, and these problems can contribute to a decision to reject a paper. To help reduce the possibility of such problems, we strongly encourage such authors to take at least one of the following steps:

• Have your manuscript reviewed for clarity by a colleague whose native language is English.
• Use one of the many English language editing services that are available, such as that offered by Nature Publishing Group Language Editing. An editor will improve the English to ensure that your meaning is clear and to identify problems that require your review.

Please note that the use of Nature Publishing Group Language Editing is at the author's own expense and in no way implies that the article will be selected for peer review or accepted by an NPG journal (or any other journal). The decisions that the editors of any NPG journal make based on the quality and suitability of a manuscript for that journal are entirely independent of whether that manuscript has been language-edited by Nature Publishing Group Language Editing.

Please press HOME to continue.